Prostate Cancer Nuclear Medicine Diagnostics Market Estimated to Grow at CAGR of 10.6% by 2028 | - Medgadget

1 year ago 53

The Insight Partners Latest Research for Report “Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028″ Includes COVID-19 Impact and Global Analysis By Type (PET and SPECT), PET Product (F-18, C-11, and Ga68-PSMA), and End User (Hospitals, Clinics and Others)

“Prostate Cancer Nuclear Medicine Diagnostics Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by Type, PET Product, and End User,” the marketplace is expected to turn from US$ 720.12 cardinal successful 2022 to US$ 1,315.66 cardinal by 2028. It is estimated to turn astatine a CAGR of 10.6% from 2022 to 2028.

Download PDF Sample Copy at:

https://www.theinsightpartners.com/sample/TIPRE00009519/

The rising prevalence of prostate crab and the surging request for aboriginal and precise diagnosis of prostate cancer. However, precocious outgo related to prostate crab diagnostics and attraction is expected to restrict the marketplace maturation during the forecast period.

Covid-19 Analysis:

COVID-19 pandemic placed important challenges connected healthcare systems, whether successful the preparation, response, oregon betterment signifier of the pandemic. This has been chiefly managed by reducing in-and out-patient services for diseases and implementing corruption prevention and power measures. As per a September 2020 published article, titled “Global Impact of COVID-19 connected Nuclear Medicine Departments, an International Survey successful April 2020,” some diagnostic and therapeutic atomic medicine procedures declined sharply to a akin grade successful countries affected by the pandemic.

Regional Overview:

According to the aforesaid source, countries, specified arsenic South Korea and Singapore reported a little pronounced interaction connected atomic medicine services. However, the wide survey results showed that atomic medicine services worldwide had an adverse effect connected the procedures. 15% of respondents experienced COVID-19 infections wrong their departments regarding unit health. Further, the maturation of the atomic medicine radioisotopes marketplace is chiefly attributed to the rising prevalence of cancer, the widening applications of atomic medicine, expanding SPECT and PET applications, and expanding diligent consciousness of radiation and radiation therapy.

Additionally, earlier the pandemic, imaging services successful Europe, chiefly the UK, suffered from chronic underinvestment with a deficiency of imaging acquisition and reporting capacity. For example, this was related to a important workforce and instrumentality shortage. But with caller IPC measures, the peculiar societal distancing of 2m successful each healthcare settings, these shortages person met CT capableness astatine the clip of penning astir 40-70% of pre-COVID levels. Also, MRI is somewhat better, accounting for 80%. Further, the imaging services are moving hard to regain momentum by restoring capableness and recovering diligent confidence. It remains wide that cardinal changes tin lone beryllium made with important concern for addressing the chronic underfunding of radiologists, radiographers, and imaging equipment.

Have a Call with Analyst:

https://www.theinsightpartners.com/speak-to-analyst/TIPRE00009519/

Segments – By Type

Based connected type, the prostate crab atomic medicine diagnostics marketplace is bifurcated into SPECT and PET. The PET conception held the largest stock of the marketplace successful 2021 and is anticipated to registry the highest CAGR during the forecast period. A Positron Emission Tomography (PET) scan is usually the astir effectual mode to restage recurrent prostate cancer. After prostate crab treatment, PET scanning whitethorn beryllium utilized to find the effectiveness of the attraction and is present commonly being utilized to observe biochemically recurrent prostate crab for restaging.

Leading Companies:

  1. Blue Earth Diagnostics Limited
  2. ImaginAB
  3. Curium
  4. Jubilant Radiopharma
  5. NCM-USA LLC
  6. ABX Advanced Biochemical Compounds GmbH
  7. Telix Pharmaceuticals Ltd.
  8. Novartis AG
  9. Theragonostics
  10. Lantheus Medical Imaging Inc

Buy Report at:

https://www.theinsightpartners.com/buy/TIPRE00009519/

About Us:
The Insight Partners is simply a 1 halt manufacture probe supplier of actionable intelligence. We assistance our clients successful getting solutions to their probe requirements done our syndicated and consulting probe services. We specialize successful industries specified arsenic Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:
If you person immoderate queries astir this study oregon if you would similar further information, delight interaction us:

Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

Read Entire Article